Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced its financial and operational results for the second quarter of fiscal year 2024, ending September 30, 2023, revealing a record positive adjusted EBITDA of CAD $3.4 million.

Miguel Martin, CEO of Aurora, stated: "This is our strongest fiscal year to date, led by robust net revenue growth in our high-margin medical cannabis segment, coupled with positive adjusted EBITDA for the fourth consecutive quarter."

See Also: Aurora Cannabis Takes Bold Step Towards Financial Recovery

Second Quarter 2024 Financial Highlights

Full story available on

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.